Niada R, Mantovani M, Prino G, Omini C, Berti F
Int J Tissue React. 1983;5(3):285-8.
Sulglycotide, a well known antisecretory and antiulcer compound, has been further investigated for its ability to protect rat gastric mucosa against extensive necrosis induced by absolute ethanol, NaOH (0.2N) and NaCl (30%). Sulglycotide, which has been compared with cimetidine, displays a dose-dependent cytoprotective activity against the above necrotizing agents. The results obtained indicate that Sulglycotide requires a normal prostaglandin biosynthetic process in order to manifest its antiulcer activity. In fact gastric mucosa from animals treated with Sulglycotide releases in vitro a greater amount of PGl2-like activity; and furthermore no protection was observed against gastric lesions induced by indomethacin. As far as the mode of action of Sulglycotide is concerned it is tempting to speculate that the compound may interfere with prostaglandin degradation or it may trigger an adaptive cytoprotection which is important in maintaining the cellular integrity of rat gastric mucosa.
舒糖肽是一种著名的抗分泌和抗溃疡化合物,人们进一步研究了它保护大鼠胃黏膜免受无水乙醇、氢氧化钠(0.2N)和氯化钠(30%)所致广泛坏死的能力。已将舒糖肽与西咪替丁进行比较,它对上述坏死剂显示出剂量依赖性的细胞保护活性。所获结果表明,舒糖肽需要正常的前列腺素生物合成过程才能发挥其抗溃疡活性。事实上,用舒糖肽处理的动物的胃黏膜在体外释放出更多的类前列环素(PGl2)活性;此外,未观察到对消炎痛所致胃损伤的保护作用。就舒糖肽的作用方式而言,推测该化合物可能干扰前列腺素降解,或者它可能引发一种适应性细胞保护,这对于维持大鼠胃黏膜的细胞完整性很重要。